US 9228188
Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
granted A61KA61K31/7105A61K33/26
Quick answer
US patent 9228188 (Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/7105, A61K33/26, A61K47/549